Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 3, 2003, Pages 256-262

  Duckworth, William ^a   Marcelli, Marco ^a   Padden, Maureen ^a   Kellick, Kenneth ^a   Duhancik, Teresa ^a   Wilhardt, Michelle ^a   Colgan, Kevin ^a   Romie, Alice ^a  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIPIZIDE; GLYCOSYLATED HEMOGLOBIN; METFORMIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GLIPIZIDE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0042650235     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.3.256     Document Type: Article

References (0)